Glycopyrronium Bromide

格隆溴铵

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameGlycopyrronium Bromide
Drug Alias Name甘罗溴铵GlycopyrrolateGlycopyrrolate bromide溴环扁比酯Bromure de glycopyrronium +[22] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsPharmaceutical aidsNeuromuscular BlockadeDepression +[20] 
Global Approved IndicationsPulmonary Disease, Chronic ObstructiveStomach UlcerDuodenal Ulcer +[5] 
Approved Indications in ChinaStomach UlcerDuodenal UlcerGastritis
Original Approved Country/TerritoryUnited States
Original Approved Date1961/08/11
Country/TerritoryCzechiaBelgiumBulgaria +[30] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesUtah State UniversityHuizheng (Shanghai) Pharmaceutical Technology Co LtdPulmosim Therapeutics LLC +[15] 
Inactive CompaniesSunovion Respiratory Development IncSosei IncVerona Pharma Plc +[12] 
Active IndicationsPharmaceutical aidsAmputation, TraumaticHyperhidrosis +[11] 
Inactive IndicationsNeuromuscular BlockadeDepressionBradycardia +[9] 

Other Information

ATC CodeA03AB02R03BB06
Related LinksWikipediaDrugBankKEGG